GEOVAX LABS, INC. Operating Lease Right-of-Use Assets
GEOVAX LABS, INC. (GOVX) had Operating Lease Right-of-Use Assets of $312.83 thousand as of 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-09-17
- 2026-06-30: Operating Lease, Right-of-Use Asset $312.83K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $384.39K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $831.44K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $0.00.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $312.83K S-1 · filed 2026-09-17 |
| 2026-03-31 | $384.39K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $831.44K S-1 · filed 2026-09-17 |
| 2024-12-31 | $0.00 S-1 · filed 2026-09-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |